News
Public · Published
Moderna: Continue to Expect About Half of 2026 Revenue to Come From U.S. and Half From International Markets >MRNA
Moderna continues to expect about half of its 2026 revenue to come from the United States and about half from international markets. The supplied article gives no further detail about products, sales amounts, or changes to this outlook.
Published:
Updated:
What happened
Moderna continues to expect about half of its 2026 revenue to come from the United States and about half from international markets. The supplied article gives no further detail about products, sales amounts, or changes to this outlook.
Confirmed
Global impact / market context
A roughly even geographic split would mean Moderna expects neither the United States nor international markets to dominate its 2026 revenue. If actual sales differ by region, the balance of revenue could shift, affecting the company’s dependence on each market.
Analyst inference
The outlook concerns where revenue is expected to come from, not a stated change in total sales or profit. Regional revenue can depend on demand and sales in each market, but the article provides no figures or explanation of those drivers.
Analyst inference
What to watch
- Compare later company updates with this expectation to see whether the projected U.S. and international shares remain about even or change. Analyst inference
- Look for later figures separating Moderna’s 2026 revenue by region; the article states an expectation but gives no regional sales amounts. Analyst inference
- Check whether Moderna later changes its stated expectation that about half of 2026 revenue will come from each region. Analyst inference
Evidence
- Original source link unavailable